Seasonality of Serum Prostate-Specific Antigen Levels: A Population-Based Study

European Urology

Volumn 52, Issue 3, 2007, Pages 708-714

  Salama, Gilles ^a   Noirot, Olivier ^b   Bataille, Vincent ^c   Malavaud, Sandra ^c   Rebillard, Xavier ^d   Villers, Arnauld ^e   Malavaud, Bernard ^f  

^a Laboratoire de Biologie   (France)

^b MÉTÉO FRANCE   (France)

^c Adimep   (France)

^d Clinique Beausoleil   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CHU RANGUEIL   (France)

Author keywords

Percent free PSA; Prostate cancer; PSA; Screening; Season; Sunshine

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; EARLY DIAGNOSIS; ENVIRONMENTAL TEMPERATURE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SEASONAL VARIATION; SUMMER; SUNLIGHT;

AGED; BIOPSY; FRANCE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEASONS; TUMOR MARKERS, BIOLOGICAL; WEATHER;

EID: 34547229293     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.11.042     Document Type: Article

References (27)

1. Lincoln G.A., Andersson H., and Loudon A. Clock genes in calendar cells as the basis of annual timekeeping in mammals-a unifying hypothesis. J Endocrinol 179 (2003) 1-13
2. Eastham J.A., Riedel E., Scardino P.T., et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 289 (2003) 2695-2700
3. Villers A., Malavaud B., Rebillard X., Bataille V., and Iborra F. ERSPC: features and preliminary results of France. BJU Int 92 Suppl 2 (2003) 27-29
4. Sokoll L.J., Bruzek D.J., Dua R., et al. Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen. Urology 60 (2002) 24-30
5. Jorgensen N., Andersen A.G., Eustache F., et al. Regional differences in semen quality in Europe. Hum Reprod 16 (2001) 1012-1019
6. Carlsen E., Petersen J.H., Andersson A.M., and Skakkebaek N.E. Effects of ejaculatory frequency and season on variations in semen quality. Fertil Steril 82 (2004) 358-366
7. Babaian R. Prostate cancer early detection. In Practice Guidelines in Oncology - v.1.2005 ed: National Comprehensive Cancer Network, 2005.
8. Partin A.W., Brawer M.K., Subong E.N., et al. Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. Prostate Cancer Prostatic Dis 1 (1998) 197-203
9. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279 (1998) 1542-1547
10. Lee R., Localio A.R., Armstrong K., Malkowicz S.B., and Schwartz J.S. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology 67 (2006) 762-768
11. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
12. Andriole G.L., Levin D.L., Crawford E.D., et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 97 (2005) 433-438
13. Bauvin E., Remontet L., and Grosclaude P. Incidence and mortality of prostate cancer in France: trends between 1978 and 2000. Prog Urol 13 (2003) 1334-1339
14. Dill D.B., and Costill D.L. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37 (1974) 247-248
15. Andersson A.M., Carlsen E., Petersen J.H., and Skakkebaek N.E. Variation in levels of serum inhibin B, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone, and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons. J Clin Endocrinol Metab 88 (2003) 932-937
16. Smolensky M.H., Reinberg A., Bicakova-Rocher A., and Sanford J. Chronoepidemiological search for circannual changes in the sexual activity of human males. Chronobiologia 8 (1981) 217-230
17. Reinberg A., and Lagoguey M. Circadian and circannual rhythms in sexual activity and plasma hormones (FSH, LH, testosterone) of five human males. Arch Sex Behav 7 (1978) 13-30
18. Herschman J.D., Smith D.S., and Catalona W.J. Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Urology 50 (1997) 239-243
19. Stenner J., Holthaus K., Mackenzie S.H., and Crawford E.D. The effect of ejaculation on prostate-specific antigen in a prostate cancer-screening population. Urology 51 (1998) 455-459
20. Lou Y.R., Qiao S., Talonpoika R., Syvala H., and Tuohimaa P. The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol 92 (2004) 317-325
21. Woitge H.W., Knothe A., Witte K., et al. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 15 (2000) 2443-2450
22. Beer T.M., Lemmon D., Lowe B.A., and Henner W.D. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 97 (2003) 1217-1224
23. Peehl D.M., and Feldman D. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer. J Steroid Biochem Mol Biol 92 (2004) 307-315
24. Krishnan A.V., Peehl D.M., and Feldman D. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. J Cell Biochem 88 (2003) 363-371
25. Rimler A., Culig Z., Lupowitz Z., and Zisapel N. Nuclear exclusion of the androgen receptor by melatonin. J Steroid Biochem Mol Biol 81 (2002) 77-84
26. Stamey T.A., Caldwell M., McNeal J.E., et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?. J Urol 172 (2004) 1297-1301
27. Patz J.A., and Khaliq M. MSJAMA: Global climate change and health: challenges for future practitioners. JAMA 287 (2002) 2283-2284